Article info
PDFShort report
Platelet aggregates, a marker of severe COVID-19 disease
- Correspondence to Dr Alexandros Rampotas, Haematology Department, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK; alexandros.rampotas{at}ouh.nhs.uk
Citation
Platelet aggregates, a marker of severe COVID-19 disease
Publication history
- Received July 9, 2020
- Revised September 16, 2020
- Accepted October 1, 2020
- First published October 16, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage